HLA-B and myeloproliferative disorder: We then utilized MHC class I multimers containing these putative mCALR neoepitopes for multiplexed screening of mCALR T cell responses in the peripheral blood of HLA-A*03:01+ and/or HLA-B*07:02+ mCALR+ MPN patients (Additional file 3).